MedWatch

Leo Pharma: A strategy for each country

The Danish company Leo Pharma does not just make use of one, but several strategies, when trying to reach out to patients. The strategies are tailored to fit the opportunities provided by the individual country, says the company’s head of sales and marketing.

Last week’s announcement from Danish Leo Pharma about a drastic change in business strategies, is an attempt to reach out to patients, create a greater level of satisfaction and ultimately secure more clients for the company’s products, says head of sales and marketing, Lars Olsen, in an interview with Medwatch.

The resignation of 300 positions within the company across Europe is a part of that change, explains the executive. Those resignations are not to be seen as cutbacks, however, but rather as an adaptation to strategies and business models used by the company.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

CHMP blåstempler ni nye lægemidler i maj

Den europæiske lægemiddelkomite, CHMP, har på dets møde i maj indstillet ni nye lægemidler til godkendelse samt anbefalet, at seks midler kan tages i brug på nye måder. To midler afvist.

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier